Synergistic anticancer effect of Pistacia lentiscus essential oils and 5-Fluorouracil co-loaded onto biodegradable nanofibers against melanoma and breast cancer
Source abstract
Abstract
Abstract Chemoresistance and severe toxicities represent major drawbacks of chemotherapy. Natural extracts, including the essential oils of Pistacia lentiscus (PLEO), exhibit substantial anticancer and anti-inflammatory activities where different cancers are reported to dramatically recess following targeting with PLEO. PLEO has promising antimicrobial, anticancer, and anti-inflammatory properties. However, the therapeutic properties of PLEO are restricted by limited stability, bioavailability, and targeting ability. PLEO nanoformulation can maximize their physicochemical and therapeutic properties, overcoming their shortcomings. Hence, PLEO was extracted and its chemical composition was determined by GC–MS. PLEO and 5-Fluorouracil (5FU) were electrospun into poly-ε-caprolactone nanofibers (PCL-NFs), of 290.71 nm to 680.95 nm diameter, to investigate their anticancer and potential synergistic activities against triple-negative breast cancer cells (MDA-MB-231), human adenocarcinoma breast cancer cells (MCF-7), and human skin melanoma cell line (A375). The prepared nanofibers (NFs) showed enhanced thermal stability and remarkable physical integrity and tensile strength. Biodegradability studies showed prolonged stability over 42 days, supporting the NFs use as a localized therapy of breast tissues (postmastectomy) or melanoma. Release studies revealed sustainable release behaviors over 168 h, with higher released amounts of 5FU and PLEO at pH 5.4, indicating higher targeting abilities towards cancer tissues. NFs loaded with PLEO showed strong antioxidant properties. Finally, NFs loaded with either PLEO or 5FU depicted greater anticancer activities compared to free compounds. The highest anticancer activities were observed with NFs co-loaded with PLEO and 5FU. The developed 5FU-PLEO-PCL-NFs hold potential as a local treatment of breast cancer tissues (post-mastectomy) and melanoma to minimize their possible recurrence. Graphical Abstract
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nuts composition and effects · Tannin, Tannase and Anticancer Activities · Cancer Treatment and Pharmacology
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30. https://doi.org/10.1002/cncr.33587.10.1002/cncr.33587 ↗
2. World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019. https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death (accessed April 1, 2023).
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.10.3322/caac.21660 ↗
4. Elston EW, Ellis IO. Method for grading breast cancer. J Clin Pathol. 1993;46(2):189. https://doi.org/10.1136/jcp.46.2.189-b.10.1136/jcp.46.2.189-b ↗
5. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC cancer staging manual continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA: Cancer J Clin. 2017;67(2):93–9.
6. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. https://doi.org/10.1038/s41572-019-0111-2.10.1038/s41572-019-0111-2 ↗
7. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002;97(1):72–81. https://doi.org/10.1002/ijc.1571.10.1002/ijc.1571 ↗
8. Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, Narod SA, Hanna WM. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Res Treat. 2009;118(1):131–7. https://doi.org/10.1007/s10549-008-0295-8.10.1007/s10549-008-0295-8 ↗
9. Taylor C, Kirby A. Cardiac side-effects from breast cancer radiotherapy. Clin Oncol. 2015;27(11):621–9. https://doi.org/10.1016/j.clon.2015.06.007.10.1016/j.clon.2015.06.007 ↗
10. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment. Cancer. 2005;104(6):1129–37. https://doi.org/10.1002/cncr.21324.10.1002/cncr.21324 ↗
11. Gilreath C, Boerma M, Qin Z, Hudson MK, Wang S. The hypoxic microenvironment of breast cancer cells promotes resistance in radiation therapy. Front Oncol. 2021;10: 629422. https://doi.org/10.3389/fonc.2020.629422.10.3389/fonc.2020.629422 ↗
12. Katzung BG, Kruidering-Hall M, Tuan RL, Vanderah TW, Trevor AJ. Cancer Chemotherapy, In Katzung & Trevor’s Pharmacology: Examination & Board Review. New York, NY: McGraw-Hill Education; 2021.
13. Nabholtz J-M, Gligorov J. The role of taxanes in the treatment of breast cancer. Expert Opin Pharmacother. 2005;6(7):1073–94. https://doi.org/10.1517/14656566.6.7.1073.10.1517/14656566.6.7.1073 ↗
14. Tao JJ, Visvanathan K, Wolff AC. Long term side effects of adjuvant chemotherapy in patients with early breast cancer. The Breast. 2015;24:S149–53. https://doi.org/10.1016/j.breast.2015.07.035.10.1016/j.breast.2015.07.035 ↗
15. Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 2008;34(4):378–90. https://doi.org/10.1016/j.ctrv.2008.01.007.10.1016/j.ctrv.2008.01.007 ↗
16. Kuderer NM, Desai A, Lustberg MB, Lyman GH. Mitigating acute chemotherapy-associated adverse events in patients with cancer. Nat Rev Clin Oncol. 2022;19(11):681–97. https://doi.org/10.1038/s41571-022-00685-3.10.1038/s41571-022-00685-3 ↗
17. Anampa J, Makower D, Sparano JA. Progress in adjuvant chemotherapy for breast cancer: an overview. BMC Med. 2015;13(1):195. https://doi.org/10.1186/s12916-015-0439-8.10.1186/s12916-015-0439-8 ↗
18. Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E, Farahmand L. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84: 106535. https://doi.org/10.1016/j.intimp.2020.106535.10.1016/j.intimp.2020.106535 ↗
19. Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Lopez BA, Barrios C, Bergh J. ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4). Ann Oncol. 2018;29(8):1634–57. https://doi.org/10.1093/annonc/mdy192.10.1093/annonc/mdy192 ↗
20. Partheniadis I, Nikolakakis I, Laidmäe I, Heinämäki J. A mini-review: needleless electrospinning of nanofibers for pharmaceutical and biomedical applications. Processes. 2020;8(6):673. https://doi.org/10.3390/pr8060673.10.3390/pr8060673 ↗
21. Rather AH, Wani TU, Khan RS, Pant B, Park M, Sheikh FA. Prospects of polymeric nanofibers loaded with essential oils for biomedical and food-packaging applications. Int J Mol Sci. 2021;22(8):4017. https://doi.org/10.3390/ijms22084017.10.3390/ijms22084017 ↗
22. Guo G, Fu S, Zhou L, Liang H, Fan M, Luo F, Qian Z, Wei Y. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale. 2011;3(9):3825–32. https://doi.org/10.1039/C1NR10484E.10.1039/C1NR10484E ↗
23. Sampath M, Lakra R, Korrapati P, Sengottuvelan B. Curcumin loaded poly (lactic-co-glycolic) acid nanofiber for the treatment of carcinoma. Colloids Surf, B. 2014;117:128–34. https://doi.org/10.1016/j.colsurfb.2014.02.020.10.1016/j.colsurfb.2014.02.020 ↗
24. Shao S, Li L, Yang G, Li J, Luo C, Gong T, Zhou S. Controlled green tea polyphenols release from electrospun PCL/MWCNTs composite nanofibers. Int J Pharm. 2011;421(2):310–20. https://doi.org/10.1016/j.ijpharm.2011.09.033.10.1016/j.ijpharm.2011.09.033 ↗
25. El Fawal G, Abu-Serie MM. Bioactive properties of nanofibers based on poly(vinylidene fluoride) loaded with oregano essential oil: Fabrication, characterization and biological evaluation. J Drug Deliv Sci Technol. 2022;69: 103133. https://doi.org/10.1016/j.jddst.2022.103133.10.1016/j.jddst.2022.103133 ↗
26. Khan AUR, Nadeem M, Bhutto MA, Yu F, Xie X, El-Hamshary H, El-Faham A, Ibrahim UA, Mo X. Physico-chemical and biological evaluation of PLCL/SF nanofibers loaded with oregano essential oil. Pharmaceutics. 2019;11(8):386. https://doi.org/10.3390/pharmaceutics11080386.10.3390/pharmaceutics11080386 ↗
27. El Fawal G, Abu-Serie MM, Omar AM. Polyvinylidene fluoride/ginger oil nanofiber scaffold for anticancer treatment: preparation, characterization, and biological evaluation. Polym Bull. 2022. https://doi.org/10.1007/s00289-022-04338-4.10.1007/s00289-022-04338-4 ↗
28. Ali M, Wani SUD, Salahuddin M, Sn M, Mruthunjaya K, Dey T, Singh J. Recent advance of herbal medicines in cancer- a molecular approach. Heliyon. 2023;9(2):e13684. https://doi.org/10.1016/j.heliyon.2023.e13684.10.1016/j.heliyon.2023.e13684 ↗
29. Aung TN, Qu Z, Kortschak RD, Adelson DL. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci. 2017;18(3):656.10.3390/ijms18030656 ↗
30. Millimouno FM, Dong J, Yang L, Li J, Li X. Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature. Cancer Prev Res. 2014;7(11):1081–107. https://doi.org/10.1158/1940-6207.Capr-14-0136.10.1158/1940-6207.Capr-14-0136 ↗
31. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils – a review. Food Chem Toxicol. 2008;46(2):446–75. https://doi.org/10.1016/j.fct.2007.09.106.10.1016/j.fct.2007.09.106 ↗
32. Raut JS, Karuppayil SM. A status review on the medicinal properties of essential oils. Ind Crops Prod. 2014;62:250–64. https://doi.org/10.1016/j.indcrop.2014.05.055.10.1016/j.indcrop.2014.05.055 ↗
33. Edris AE. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res. 2007;21(4):308–23. https://doi.org/10.1002/ptr.2072.10.1002/ptr.2072 ↗
34. Kaefer CM, Milner JA. The role of herbs and spices in cancer prevention. J Nutr Biochem. 2008;19(6):347–61. https://doi.org/10.1016/j.jnutbio.2007.11.003.10.1016/j.jnutbio.2007.11.003 ↗
35. Hamid A, Aiyelaagbe O, Usman L. Essential oils: Its medicinal and pharmacological uses. Int J Curr Res. 2011;33:86–98.
36. AbouAitah K, Lojkowski W. Nanomedicine as an emerging technology to foster application of essential oils to fight cancer. Pharmaceuticals. 2022;15(7):793. https://doi.org/10.3390/ph15070793.10.3390/ph15070793 ↗
37. Salvioni L, Rizzuto MA, Bertolini JA, Pandolfi L, Colombo M, Prosperi D. Thirty years of cancer nanomedicine: success, frustration, and hope. Cancers. 2019;11(12):1855. https://doi.org/10.3390/cancers11121855.10.3390/cancers11121855 ↗
38. Alabrahim OAA, Alwahibi S, Azzazy HME-S. Improved antimicrobial activities of boswellia sacra essential oils nanoencapsulated into hydroxypropyl-beta-cyclodextrins. Nanoscale Adv. 2024. https://doi.org/10.1039/D3NA00882G.10.1039/D3NA00882G ↗
39. Alabrahim OAA, Fahmy SA, Azzazy HME-S. Stimuli-responsive cucurbit[n]uril-based supramolecular nanocarriers for delivery of chemotherapeutics. ACS Appl Nano Mater. 2023;6(5):3139–58. https://doi.org/10.1021/acsanm.2c05391.10.1021/acsanm.2c05391 ↗
40. Alabrahim OAA, Azzazy HME-S. Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson’s disease. Nanoscale Adv. 2022;4(24):5233–44. https://doi.org/10.1039/D2NA00524G.10.1039/D2NA00524G ↗
41. Fahmy SA, Sedky NK, Ramzy A, Abdelhady MMM, Alabrahim OAA, Shamma SN, Azzazy HME-S. Green extraction of essential oils from Pistacia lentiscus resins: Encapsulation into Niosomes showed improved preferential cytotoxic and apoptotic effects against breast and ovarian cancer cells. J Drug Deliv Sci Technol. 2023;87: 104820. https://doi.org/10.1016/j.jddst.2023.104820.10.1016/j.jddst.2023.104820 ↗
42. Chen J, Jiang Z, Xu W, Sun T, Zhuang X, Ding J, Chen X. Spatiotemporally targeted nanomedicine overcomes hypoxia-induced drug resistance of tumor cells after disrupting neovasculature. Nano Lett. 2020;20(8):6191–8. https://doi.org/10.1021/acs.nanolett.0c02515.10.1021/acs.nanolett.0c02515 ↗
43. Kemp JA, Shim MS, Heo CY, Kwon YJ. “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev. 2016;98:3–18. https://doi.org/10.1016/j.addr.2015.10.019.10.1016/j.addr.2015.10.019 ↗
44. Perry JL, Reuter KG, Luft JC, Pecot CV, Zamboni W, DeSimone JM. Mediating passive tumor accumulation through particle size, tumor type, and location. Nano Lett. 2017;17(5):2879–86. https://doi.org/10.1021/acs.nanolett.7b00021.10.1021/acs.nanolett.7b00021 ↗
45. de la Rica R, Aili D, Stevens MM. Enzyme-responsive nanoparticles for drug release and diagnostics. Adv Drug Deliv Rev. 2012;64(11):967–78. https://doi.org/10.1016/j.addr.2012.01.002.10.1016/j.addr.2012.01.002 ↗
46. Niemirowicz K, Markiewicz KH, Wilczewska AZ, Car H. Magnetic nanoparticles as new diagnostic tools in medicine. Adv Med Sci. 2012;57(2):196–207. https://doi.org/10.2478/v10039-012-0031-9.10.2478/v10039-012-0031-9 ↗
47. Davis RM, Campbell JL, Burkitt S, Qiu Z, Kang S, Mehraein M, Miyasato D, Salinas H, Liu JTC, Zavaleta C. A raman imaging approach using CD47 antibody-labeled SERS nanoparticles for identifying breast cancer and its potential to guide surgical resection. Nanomaterials. 2018;8(11):953. https://doi.org/10.3390/nano8110953.10.3390/nano8110953 ↗
48. Xie J, Gong L, Zhu S, Yong Y, Gu Z, Zhao Y. Emerging strategies of nanomaterial-mediated tumor radiosensitization. Adv Mater. 2019;31(3):1802244. https://doi.org/10.1002/adma.201802244.10.1002/adma.201802244 ↗
49. Kemp JA, Kwon YJ. Cancer nanotechnology: current status and perspectives. Nano Converg. 2021;8(1):34. https://doi.org/10.1186/s40580-021-00282-7.10.1186/s40580-021-00282-7 ↗
50. Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, Hamishehkar H, Hamblin MR. Nanovehicles for co-delivery of anticancer agents. Drug Discov Today. 2020;25(8):1416–30. https://doi.org/10.1016/j.drudis.2020.06.027.10.1016/j.drudis.2020.06.027 ↗
51. Asadollahi L, Mahoutforoush A, Dorreyatim SS, Soltanfam T, Paiva-Santos AC, Peixoto D, Veiga F, Hamishehkar H, Zeinali M, Abbaspour-Ravasjani S. Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: a synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation. Int J Pharm. 2022;624: 122027. https://doi.org/10.1016/j.ijpharm.2022.122027.10.1016/j.ijpharm.2022.122027 ↗
52. Mansoori B, Mohammadi A, Abedi-Gaballu F, Abbaspour S, Ghasabi M, Yekta R, Shirjang S, Dehghan G, Hamblin MR, Baradaran B. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells. J Cell Physiol. 2020;235(10):6817–30. https://doi.org/10.1002/jcp.29576.10.1002/jcp.29576 ↗
53. Leena MM, Yoha KS, Moses JA, Anandharamakrishnan C. 3.37 - Nanofibers in Food Applications. In: Knoerzer K, Muthukumarappan K, editors. Innovative Food Processing Technologies. Oxford: Elsevier; 2021. p. 634–50.10.1016/B978-0-08-100596-5.22952-1 ↗
54. Xie F, Wang Y, Zhuo L, Jia F, Ning D, Lu Z. Electrospun wrinkled porous polyimide nanofiber-based filter via thermally induced phase separation for efficient high-temperature PMs capture. ACS Appl Mater Interf. 2020;12(50):56499–508. https://doi.org/10.1021/acsami.0c18143.10.1021/acsami.0c18143 ↗
55. Zheng Z, Chen P, Xie M, Wu C, Luo Y, Wang W, Jiang J, Liang G. Cell environment-differentiated self-assembly of nanofibers. J Am Chem Soc. 2016;138(35):11128–31. https://doi.org/10.1021/jacs.6b06903.10.1021/jacs.6b06903 ↗
56. Yan J, Han Y, Xia S, Wang X, Zhang Y, Yu J, Ding B. Polymer template synthesis of flexible BaTiO3 crystal nanofibers. Adv Func Mater. 2019;29(51):1907919. https://doi.org/10.1002/adfm.201907919.10.1002/adfm.201907919 ↗
57. Li Y, Zhu J, Cheng H, Li G, Cho H, Jiang M, Gao Q, Zhang X. Developments of advanced electrospinning techniques: a critical review. Adv Mater Technol. 2021;6(11):2100410. https://doi.org/10.1002/admt.202100410.10.1002/admt.202100410 ↗
58. Karkanrood MV, Homayouni Tabrizi M, Ardalan T, Soltani M, Khadem F, Nosrat T, Moeini S. Pistacia atlantica fruit essential oil nanoemulsions (PAEO-NE), an effective antiangiogenic therapeutic and cell-dependent apoptosis inducer on A549 human lung cancer cells. Inorganic Nano-Metal Chem. 2022. https://doi.org/10.1080/24701556.2022.2034008.10.1080/24701556.2022.2034008 ↗
59. Milia E, Bullitta SM, Mastandrea G, Szotáková B, Schoubben A, Langhansová L, Quartu M, Bortone A, Eick S. Leaves and fruits preparations of Pistacia lentiscus L.: a review on the ethnopharmacological uses and implications in inflammation and infection. Antibiotics. 2021;10(4):425. https://doi.org/10.3390/antibiotics10040425.10.3390/antibiotics10040425 ↗
60. Soulaidopoulos S, Tsiogka A, Chrysohoou C, Lazarou E, Aznaouridis K, Doundoulakis I, Tyrovola D, Tousoulis D, Tsioufis K, Vlachopoulos C, Lazaros G. Overview of Chios Mastic Gum (Pistacia lentiscus) effects on human health. Nutrients. 2022;14(3):590. https://doi.org/10.3390/nu14030590.10.3390/nu14030590 ↗
61. Pachi VK, Mikropoulou EV, Gkiouvetidis P, Siafakas K, Argyropoulou A, Angelis A, Mitakou S, Halabalaki M. Traditional uses, phytochemistry and pharmacology of Chios mastic gum (Pistacia lentiscus var. Chia, Anacardiaceae): a review. J Ethnopharmacol. 2020;254:112485. https://doi.org/10.1016/j.jep.2019.112485.10.1016/j.jep.2019.112485 ↗
62. Mahjoub F, Rezayat KA, Yousefi M, Mohebbi M, Salari R. Pistacia atlantica Desf. a review of its traditional uses, phytochemicals and pharmacology. J Med Life. 2018;11(3):180.10.25122/jml-2017-0055 ↗
63. Ahmed ZB, Yousfi M, Viaene J, Dejaegher B, Demeyer K, Vander Heyden Y. Four Pistacia atlantica subspecies (atlantica, cabulica, kurdica and mutica): a review of their botany, ethnobotany, phytochemistry and pharmacology. J Ethnopharmacol. 2021;265: 113329. https://doi.org/10.1016/j.jep.2020.113329.10.1016/j.jep.2020.113329 ↗
64. Ahmad R, Almubayedh H, Ahmad N, Naqvi AA, Riaz M. Ethnobotany, ethnopharmacology, phytochemistry, biological activities and toxicity of Pistacia chinensis subsp integerrima: a comprehensive review. Phytother Res. 2020;34(11):2793–819. https://doi.org/10.1002/ptr.6720.10.1002/ptr.6720 ↗
65. Rauf A, Patel S, Uddin G, Siddiqui BS, Ahmad B, Muhammad N, Mabkhot YN, Hadda TB. Phytochemical, ethnomedicinal uses and pharmacological profile of genus Pistacia. Biomed Pharmacother. 2017;86:393–404. https://doi.org/10.1016/j.biopha.2016.12.017.10.1016/j.biopha.2016.12.017 ↗
66. Kirollos F, Elhawary S, Salama O, Elkhawas Y. LC-ESI-MS/MS and cytotoxic activity of three Pistacia species. Nat Prod Res. 2019;33(12):1747–50. https://doi.org/10.1080/14786419.2018.1428601.10.1080/14786419.2018.1428601 ↗
67. Spyridopoulou K, Tiptiri-Kourpeti A, Lampri E, Fitsiou E, Vasileiadis S, Vamvakias M, Bardouki H, Goussia A, Malamou-Mitsi V, Panayiotidis MI, Galanis A, Pappa A, Chlichlia K. Dietary mastic oil extracted from Pistacia lentiscus var. chia suppresses tumor growth in experimental colon cancer models. Sci Rep. 2017;7(1):3782. https://doi.org/10.1038/s41598-017-03971-8.10.1038/s41598-017-03971-8 ↗
68. Magkouta S, Stathopoulos GT, Psallidas I, Papapetropoulos A, Kolisis FN, Roussos C, Loutrari H. Protective effects of mastic oil from pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma. Nutr Cancer. 2009;61(5):640–8. https://doi.org/10.1080/01635580902825647.10.1080/01635580902825647 ↗
69. Loutrari H, Magkouta S, Pyriochou A, Koika V, Kolisis FN, Papapetropoulos A, Roussos C. Mastic oil from pistacia lentiscus var chia inhibits growth and survival of human K562 leukemia cells and attenuates angiogenesis. Nutr Cancer. 2006;55(1):86–93. https://doi.org/10.1207/s15327914nc5501_11.10.1207/s15327914nc5501_11 ↗
70. Najjari N, Sari S, Saffari M, Kelidari H, Nokhodchi A. Formulation optimization and characterization of Pistacia atlantica Desf. essential oil-loaded nanostructured lipid carriers on the proliferation of human breast cancer cell line SKBR3 (in vitro studies). J Herbal Med. 2022;36:100600. https://doi.org/10.1016/j.hermed.2022.100600.10.1016/j.hermed.2022.100600 ↗
71. Dousti M, Sari S, Saffari M, Kelidari H, Asare-Addo K, Nokhodchi A. Loading Pistacia atlantica essential oil in solid lipid nanoparticles and its effect on apoptosis of breast cancer cell line MDA-MB-231. Pharm Dev Technol. 2022;27(1):63–71. https://doi.org/10.1080/10837450.2021.2022693.10.1080/10837450.2021.2022693 ↗
72. Vrouvaki I, Koutra E, Kornaros M, Avgoustakis K, Lamari FN, Hatziantoniou S. Polymeric nanoparticles of Pistacia lentiscus var. chia essential oil for cutaneous applications. Pharmaceutics. 2020;12(4):353. https://doi.org/10.3390/pharmaceutics12040353.10.3390/pharmaceutics12040353 ↗
73. El-Chaghaby GA, Ahmad AF. Biosynthesis of silver nanoparticles using Pistacia lentiscus leaves extract and investigation of their antimicrobial effect. Oriental J Chem. 2011;27(3):929.
74. Gortzi O, Rovoli M, Katsoulis K, Graikou K, Karagkini D-A, Stagos D, Kouretas D, Tsaknis J, Chinou I. Study of stability, cytotoxic and antimicrobial activity of chios mastic gum fractions (neutral, acidic) after encapsulation in liposomes. Foods. 2022;11(3):271. https://doi.org/10.3390/foods11030271.10.3390/foods11030271 ↗
75. Pachi VK, Mikropoulou EV, Dimou S, Dionysopoulou M, Argyropoulou A, Diallinas G, Halabalaki M. Chemical Profiling of Pistacia lentiscus var. chia resin and essential oil: ageing markers and antimicrobial activity. Processes. 2021;9(3):418. https://doi.org/10.3390/pr9030418.10.3390/pr9030418 ↗
76. Tabanca N, Nalbantsoy A, Kendra PE, Demirci F, Demirci B. Chemical characterization and biological activity of the mastic gum essential oils of Pistacia lentiscus var. chia from Turkey. Molecules. 2020;25(9):2136. https://doi.org/10.3390/molecules25092136.10.3390/molecules25092136 ↗
77. Shin M, Ishii O, Sueda T, Vacanti JP. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials. 2004;25(17):3717–23. https://doi.org/10.1016/j.biomaterials.2003.10.055.10.1016/j.biomaterials.2003.10.055 ↗
78. Ishii O, Shin M, Sueda T, Vacanti JP. In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix–like topography. J Thorac Cardiovasc Surg. 2005;130(5):1358–63. https://doi.org/10.1016/j.jtcvs.2005.05.048.10.1016/j.jtcvs.2005.05.048 ↗
79. He ML, Yuan HQ, Jiang AL, Gong AY, Chen WW, Zhang PJ, Young CY, Zhang JY. Gum mastic inhibits the expression and function of the androgen receptor in prostate cancer cells. Cancer. 2006;106(12):2547–55. https://doi.org/10.1002/cncr.21935.10.1002/cncr.21935 ↗
80. He ML, Li A, Xu CS, Wang SL, Zhang MJ, Gu H, Yang YQ, Tao HH. Mechanisms of antiprostate cancer by gum mastic: NF-kappaB signal as target. Acta Pharmacol Sin. 2007;28(3):446–52. https://doi.org/10.1111/j.1745-7254.2007.00536.x.10.1111/j.1745-7254.2007.00536.x ↗
81. Fitsiou E, Pappa A. Anticancer activity of essential oils and other extracts from aromatic plants grown in Greece. Antioxidants (Basel). 2019. https://doi.org/10.3390/antiox8080290.10.3390/antiox8080290 ↗
82. Bouyahya A, Chadon Assemian IC, Mouzount H, Bourais I, Et-Touys A, Fellah H, Benjouad A, Dakka N, Bakri Y. Could volatile compounds from leaves and fruits of Pistacia lentiscus constitute a novel source of anticancer, antioxidant, antiparasitic and antibacterial drugs? Ind Crops Prod. 2019;128:62–9. https://doi.org/10.1016/j.indcrop.2018.11.001.10.1016/j.indcrop.2018.11.001 ↗
83. Wińska P, Karatsai O, Staniszewska M, Koronkiewicz M, Chojnacki K, Rędowicz MJ. Synergistic interactions of 5-Fluorouracil with inhibitors of protein kinase CK2 correlate with p38 MAPK activation and FAK inhibition in the triple-negative breast cancer cell line. Int J Mol Sci. 2020;21(17):6234. https://doi.org/10.3390/ijms21176234.10.3390/ijms21176234 ↗
84. Azzazy HME-S, Abdelnaser A, Al Mulla H, Sawy AM, Shamma SN, Elhusseiny M, Alwahibi S, Mahdy NK, Fahmy SA. Essential oils extracted from boswellia sacra oleo gum resin loaded into PLGA–PCL nanoparticles: enhanced cytotoxic and apoptotic effects against breast cancer cells. ACS Omega. 2023;8(1):1017–25. https://doi.org/10.1021/acsomega.2c06390.10.1021/acsomega.2c06390 ↗
85. Kesici Güler H, Cengiz Çallıoğlu F, Sesli Çetin E. Antibacterial PVP/cinnamon essential oil nanofibers by emulsion electrospinning. J Textile Inst. 2019;110(2):302–10. https://doi.org/10.1080/00405000.2018.1477237.10.1080/00405000.2018.1477237 ↗
86. Mirzaeei S, Mansurian M, Asare-Addo K, Nokhodchi A. Metronidazole- and amoxicillin-loaded PLGA and PCL nanofibers as potential drug delivery systems for the treatment of periodontitis in vitro and in vivo evaluations. Biomedicines. 2021;9(8):975.10.3390/biomedicines9080975 ↗
87. Dadras Chomachayi M, Solouk A, Akbari S, Sadeghi D, Mirahmadi F, Mirzadeh H. Electrospun nanofibers comprising of silk fibroin/gelatin for drug delivery applications: Thyme essential oil and doxycycline monohydrate release study. J Biomed Mater Res, Part A. 2018;106(4):1092–103. https://doi.org/10.1002/jbm.a.36303.10.1002/jbm.a.36303 ↗
88. Khunová V, Kováčová M, Olejniková P, Ondreáš F, Špitalský Z, Ghosal K, Berkeš D. Antibacterial electrospun polycaprolactone nanofibers reinforced by halloysite nanotubes for tissue engineering. Polymers. 2022;14(4):746. https://doi.org/10.3390/polym14040746.10.3390/polym14040746 ↗
89. Peresin MS, Vesterinen AH, Habibi Y, Johansson LS, Pawlak JJ, Nevzorov AA, Rojas OJ. Crosslinked PVA nanofibers reinforced with cellulose nanocrystals: Water interactions and thermomechanical properties. J Appl Polymer Sci. 2014. https://doi.org/10.1002/app.40334.10.1002/app.40334 ↗
90. Amer SS, Mamdouh W, Nasr M, ElShaer A, Polycarpou E, Abdel-Aziz RTA, Sammour OA. Quercetin loaded cosm-nutraceutical electrospun composite nanofibers for acne alleviation: Preparation, characterization and experimental clinical appraisal. Int J Pharm. 2022;612: 121309. https://doi.org/10.1016/j.ijpharm.2021.121309.10.1016/j.ijpharm.2021.121309 ↗
91. Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, Maibach H, Marques M, Rytting H, Shaw S, Thakker K. In Topical and transdermal drug products. Pharmacopeial forum. 2009;35:750–64.
92. Patel SU, Manzo GM, Patel SU, Kulkarni PS, Chase GG. Permeability of electrospun superhydrophobic nanofiber mats. J Nanotechnol. 2012. https://doi.org/10.1155/2012/483976.10.1155/2012/483976 ↗
93. Mozaffari S, Seyedabadi S, Alemzadeh E. Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence. J Drug Deliv Sci Technol. 2022;67: 102984. https://doi.org/10.1016/j.jddst.2021.102984.10.1016/j.jddst.2021.102984 ↗
94. Pinzón-García AD, Sinisterra R, Cortes M, Mesa F, Ramírez-Clavijo S. Polycaprolactone nanofibers as an adjuvant strategy for Tamoxifen release and their cytotoxicity on breast cancer cells. PeerJ. 2021;9: e12124. https://doi.org/10.7717/peerj.12124.10.7717/peerj.12124 ↗
95. Bazgir M, Zhang W, Zhang X, Elies J, Saeinasab M, Coates P, Youseffi M, Sefat F. Degradation and Characterisation of Electrospun Polycaprolactone (PCL) and Poly(lactic-co-glycolic acid) (PLGA) Scaffolds for Vascular Tissue Engineering. Materials. 2021;14(17):4773. https://doi.org/10.3390/ma14174773.10.3390/ma14174773 ↗
96. Varshosaz J, Sajadi-Javan ZS, Kouhi M, Mirian M. Effect of bassorin (derived from gum tragacanth) and halloysite nanotubes on physicochemical properties and the osteoconductivity of methylcellulose-based injectable hydrogels. Int J Biol Macromol. 2021;192:869–82. https://doi.org/10.1016/j.ijbiomac.2021.10.009.10.1016/j.ijbiomac.2021.10.009 ↗
97. Selvaraj S, Fathima NN. Fenugreek incorporated silk fibroin nanofibers—a potential antioxidant scaffold for enhanced wound healing. ACS Appl Mater Interf. 2017;9(7):5916–26. https://doi.org/10.1021/acsami.6b16306.10.1021/acsami.6b16306 ↗
98. Marincaș L, Farkas N-I, Barbu-Tudoran L, Barabás R, Toşa MI. Deep eutectic solvent PCL-based nanofibers as drug delivery system. Mater Chem Phys. 2023;304: 127862. https://doi.org/10.1016/j.matchemphys.2023.127862.10.1016/j.matchemphys.2023.127862 ↗
99. Wassif RK, Elkheshen SA, Shamma RN, Amer MS, Elhelw R, El-kayal M. Injectable systems of chitosan in situ forming composite gel incorporating linezolid-loaded biodegradable nanoparticles for long-term treatment of bone infections. Drug Deliv Transl Res. 2024;14(1):80–102. https://doi.org/10.1007/s13346-023-01384-x.10.1007/s13346-023-01384-x ↗
100. Hatem S, Elkheshen SA, Kamel AO, Nasr M, Moftah NH, Ragai MH, Elezaby RS, El Hoffy NM. Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment. Drug Deliv. 2022;29(1):1212–31. https://doi.org/10.1080/10717544.2022.2058652.10.1080/10717544.2022.2058652 ↗